Highlight
This comparative study of Japanese heart failure (HF) registries demonstrated significant temporal improvements in clinical practice and patient outcomes from 2013 to 2019-21. Key highlights include increased use of guideline-recommended pharmacotherapies such as renin-angiotensin system inhibitors and beta-blockers, expanded implementation of cardiac rehabilitation and nutritional guidance, and notable reductions in 1-year mortality and HF readmission rates.
